The Impact of Advancements in Genomics on the Companion Diagnostics Market
Beyond oncology, autoimmune disorders such as rheumatoid arthritis and lupus present new opportunities for the Companion Diagnostics Market.
These complex diseases often require long-term treatment, and patients may respond differently to the same medication. Companion diagnostics can help identify which patients are most likely to benefit from specific biologic therapies, minimizing trial-and-error prescribing and improving patient outcomes.
4 Views